Product
Help
Pricing
About
Jobs
Log in
Get started
Institution
Add to collection
Sanofi (Portugal)
Homepage:
sanofi.com
Parent institution:
Sanofi (France)
ROR:
00704c791
OpenAlex ID:
I4405253000
Long‐term follow‐up of patients treated with caplacizumab and safety and efficacy of repeat caplacizumab use: Post‐HERCULES study
2022
·
Marie Scully
, Javier de la Rubia
, et al.
·
Journal of Thrombosis and Haemostasis
·
42
PDF
Excess hospitalizations and mortality associated with seasonal influenza in Portugal, 2008–2018
2022
·
Filipe Froes
, Mafalda Carmo
, et al.
·
BMC Infectious Diseases
·
31
PDF
Caplacizumab Model‐Based Dosing Recommendations in Pediatric Patients With Acquired Thrombotic Thrombocytopenic Purpura
2021
·
Martin Bergstrand
, Emma Hansson
, et al.
·
The Journal of Clinical Pharmacology
·
30
Human Papillomavirus Type Distribution in Cervical Intraepithelial Neoplasia Grade 2/3 and Cervical Cancer in Portugal
2013
·
Angela Pista
, Carlos Freire de Oliveira
, et al.
·
International Journal of Gynecological Cancer
·
30
Cost-effectiveness of influenza vaccination with a high dose quadrivalent vaccine of the elderly population in Belgium, Finland, and Portugal
2023
·
Fabián P. Alvarez
, Pierre Chevalier
, et al.
·
Journal of Medical Economics
·
28
PDF
Burden and severity of children's hospitalizations by respiratory syncytial virus in Portugal, 2015–2018
2022
·
Teresa Bandeira
, Mafalda Carmo
, et al.
·
Influenza and Other Respiratory Viruses
·
28
PDF
Risk factors for human papillomavirus infection among women in Portugal: The CLEOPATRE Portugal Study
2012
·
Angela Pista
, Carlos F. de Oliveira
, et al.
·
International Journal of Gynecology & Obstetrics
·
20
Epidemiology, treatment patterns, clinical outcomes, and disease burden among patients with immune‐mediated thrombotic thrombocytopenic purpura in the United States
2022
·
Ayoade Adeyemi
, Francesca Razakariasa
, et al.
·
Research and Practice in Thrombosis and Haemostasis
·
17
The Vacinómetro® initiative: an eleven-year monitorization of influenza vaccination coverage rates among risk groups in Portugal
2022
·
F. Froes
, A. Morais
, et al.
·
Pulmonology
·
14
The societal role of lifelong vaccination
2015
·
Maarten J. Postma
, Stuart Carroll
, et al.
·
Journal of Market Access & Health Policy
·
11
PDF
Uncovering the burden of Influenza in children in Portugal, 2008–2018
2024
·
Alberto Caldas Afonso
, Catarina Gouveia
, et al.
·
BMC Infectious Diseases
·
10
PDF
Long-term efficacy and safety of alemtuzumab in participants with highly active MS: TOPAZ clinical trial and interim analysis of TREAT-MS real-world study
2025
·
Tjalf Ziemssen
, Ann D. Bass
, et al.
·
Therapeutic Advances in Neurological Disorders
·
6
Macrogol: Evaluación de la percepción de efectividad y calidad de vida en individuos con estreñimiento
2022
·
Nuno Correia
, Francisco Guarner
, et al.
·
Ars Pharmaceutica (Internet)
·
6
PDF
Potential impact of nonavalent HPV vaccine in the prevention of high‐grade cervical lesions and cervical cancer in Portugal
2017
·
Angela Pista
, Carlos Freire de Oliveira
, et al.
·
International Journal of Gynecology & Obstetrics
·
6
The burden of atopic dermatitis in Portuguese patients: an observational study
2024
·
Pedro S. Coelho
, Miguel Apalhão
, et al.
·
Scientific Reports
·
5
PDF
Los costes indirectos de la cefalea tensional. Una revisión sistemática de la literatura
2022
·
Juan Ernesto del Llano Señarís
, Nuno Nunes Correia
, et al.
·
Atención Primaria
·
5
PDF
Long-Term Safety and Efficacy of Caplacizumab for Acquired Thrombotic Thrombocytopenic Purpura (aTTP): The Post-HERCULES Study
2021
·
Marie Scully
, Javier de la Rubia
, et al.
·
Blood
·
4
Efficacy of Caplacizumab in Patients with aTTP in the HERCULES Study According to Baseline Disease Severity
2019
·
Paul Coppo
, Spero Cataland
, et al.
·
Blood
·
4
Outcomes and Costs in Patients with Immune Thrombotic Thrombocytopenic Purpura Receiving Front-Line Versus Delayed Caplacizumab: A US Hospital Database Study
2024
·
Alix Arnaud
, Samantha Schilsky
, et al.
·
Clinical and Applied Thrombosis/Hemostasis
·
2
POSB368 Understanding the Impact of Atopic Dermatitis in Portuguese Patients: Results from an Analytical Observational Study
2022
·
P Coelho
, M Alpalhão
, et al.
·
Value in Health
·
2
PDF
Efficacy of Caplacizumab in Patients with aTTP in the HERCULES Study According to Initial Immunosuppression Regimen
2019
·
Katerina Pavenski
, Paul Knoebl
, et al.
·
Blood
·
2
EE348 Number Needed to Treat and Cost-per-Responder Analysis of Dupilumab and Mepolizumab in Chronic Rhinosinusitis With Nasal Polyps
2024
·
L Dreyfus
, J Tavi
, et al.
·
Value in Health
·
1
PDF
PRO61 Identify Patients with RARE Diseases in Portugal: acquired Thrombotic Thrombocytopenic Purpura (aTTP)
2020
·
R. Sousa
, S. Andrade
, et al.
·
Value in Health
·
1
Safety of caplacizumab in patients without documented severe adamts13 deficiency during the hercules study
2020
·
S. Besisik
, J. De La Rubia
, et al.
·
Hematology Transfusion and Cell Therapy
·
1
PDF
Caplacizumab induces fast and durable platelet count responses with improved time to complete remission and recurrence-free survival in patients with acquired thrombotic thrombocytopenic purpura
2020
·
L. Kaynar
, P. Coppo
, et al.
·
Hematology Transfusion and Cell Therapy
·
1
PDF
Show more works
View as search
Works count:
51
Citation count:
385
Year
Topic
Type
